Oncology
2301 articles · 70 journals
Journals in this subcategory (70)
- Blood Neoplasia · Elsevier (95)
- European Journal of Surgical Oncology · Elsevier (90)
- Biochimica et Biophysica Acta: Reviews on Cancer · Elsevier (89)
- Cancer Treatment and Research Communications · Elsevier (88)
- The Lancet Oncology · Elsevier (88)
- Brachytherapy · Elsevier (86)
- Cancer Epidemiology · Elsevier (85)
- International Journal of Gynecological Cancer · Elsevier (83)
- Journal of Thoracic Oncology · Elsevier (82)
- EJC Skin Cancer · Elsevier (81)
- Lung Cancer · Elsevier (73)
- Asia-Pacific Journal of Clinical Oncology · Wiley (72)
- Critical Reviews in Oncology/Hematology · Elsevier (69)
- Surgical Oncology Clinics of North America · Elsevier (66)
- European Journal of Cancer · Elsevier (65)
- Leukemia Research Reports · Elsevier (65)
- Gynecologic Oncology Reports · Elsevier (64)
- Urologic Oncology: Seminars and Original Investigations · Elsevier (63)
- Bulletin du Cancer · Elsevier (59)
- Translational Oncology · Elsevier (59)
- Blood Reviews · Elsevier (54)
- Cancer Letters · Elsevier (53)
- Journal of the National Cancer Center · Elsevier (53)
- Leukemia Research · Elsevier (52)
- The Journal of Liquid Biopsy · Elsevier (52)
- Trends in Cancer · Elsevier (49)
- JACC: CardioOncology · Elsevier (46)
- Surgical Oncology Insight · Elsevier (43)
- Clinical Breast Cancer · Elsevier (40)
- ESMO Open · Elsevier (38)
- Cancer Pathogenesis and Therapy · Elsevier (37)
- Clinical Lung Cancer · Elsevier (33)
- Journal of Geriatric Oncology · Elsevier (30)
- Current Problems in Cancer: Case Reports · Elsevier (29)
- Journal of Bone Oncology · Elsevier (27)
- Precision Radiation Oncology · Wiley (20)
- Intelligent Oncology · Elsevier (19)
- Current Problems in Cancer · Elsevier (17)
- Immuno-Oncology and Technology · Elsevier (16)
- npj Precision Oncology · Springer Nature (12)
- Best Practice & Research Clinical Haematology · Elsevier (11)
- MedComm - Oncology · Wiley (10)
- European Journal of Cancer: Supplement · Elsevier (9)
- Nature Reviews Cancer · Springer Nature (9)
- Nature Reviews Clinical Oncology · Springer Nature (8)
- British Journal of Cancer · Springer Nature (7)
- Cancer Cytopathology · Wiley (5)
- BMC Cancer · Springer Nature (0)
- Breast Cancer Research · Springer Nature (0)
- Breast Cancer Research and Treatment · Springer Nature (0)
- Cancer Cell International · Springer Nature (0)
- Cancer Chemotherapy and Pharmacology · Springer Nature (0)
- Cancer and Metastasis Reviews · Springer Nature (0)
- Cardio-Oncology · Springer Nature (0)
- Cellular Oncology · Springer Nature (0)
- Clinical and Translational Oncology · Springer Nature (0)
- Current Breast Cancer Reports · Springer Nature (0)
- Current Hematologic Malignancy Reports · Springer Nature (0)
- Current Oncology Reports · Springer Nature (0)
- Immuno-Oncology · Springer Nature (0)
- Indian Journal of Gynecologic Oncology · Springer Nature (0)
- Indian Journal of Surgical Oncology · Springer Nature (0)
- Journal of Cancer Research and Clinical Oncology · Springer Nature (0)
- Journal of Gastrointestinal Cancer · Springer Nature (0)
- Journal of Mammary Gland Biology and Neoplasia · Springer Nature (0)
- Journal of the Egyptian National Cancer Institute · Springer Nature (0)
- Molecular Cancer · Springer Nature (0)
- Oncology and Therapy · Springer Nature (0)
- Strahlentherapie und Onkologie · Springer Nature (0)
- best practice onkologie · Springer Nature (0)
- Momelotinib induces hemoglobin improvement and symptom control in PCM1::JAK2-associated myeloid neoplasm
- Luvometinib as a salvage therapy for a patient with PTPN11-positive juvenile myelomonocytic leukemia
- Real-world outcomes after second-line therapy in chronic lymphocytic leukemia: A population-based study
- CDC20 and CEP55: essential players for pathogenesis of chromosomal abnormalities in MDS?
- SARS-CoV-2 mRNA Vaccination Improved Survival in NSCLC Treated With Radiotherapy
- Can Postoperative Pathology Guide Preoperative Segmentectomy Decisions?
- A Response to the Letter to the Editor: “Can postoperative pathology guide preoperative segmentectomy decisions?”
- Percent Thymic Tissue and Pneumonitis Risk in Locally Advanced NSCLC: From Predictive Signal to Clinical Actionability
- A Response to the Letter to the Editor: “Percent Thymic Tissue and Pneumonitis Risk in Locally Advanced NSCLC: From Predictive Signal to Clinical Actionability”
- Brief Report: Characterization of the Potentially Actionable TP53 Y220C Mutation in Non-Small Cell Lung Cancer. A Multicenter, European Thoracic Oncology Platform Study
- Amivantamab-Induced Capillary Leak Syndrome Successfully Treated With Intravenous Immunoglobulin Administration: Case Report
- Development and Implementation of an Integrated Early Lung Cancer Detection Program in Ethiopia: A Scalable Framework for Resource-Constrained Settings
- Brief report: Clinical and Functional Characterization of Rare Germline and Somatic EGFR Variants in Three Patients with Non-Small Cell Lung Cancer
- Editorial Board
- Board of Directors
- Meeting Announcements
- Table of Contents
- In This Issue
- Tobacco News Update - From the IASLC Tobacco Control Committee
- The Price of Progress in Lung Cancer: Global Disparities, Drug Costs, and the Challenge of Equitable Access
- The Weight of Success: Managing Visceral Adiposity in the Lorlatinib Era
- Finding Synergy Without Sacrificing Safety: Novel Combination Therapies in NSCLC
- Is Homozygous Methylthioadenosine Phosphorylase Deletion (MTAP−/−) in NSCLC an Important, Actionable, Adverse Prognostic Factor in Both Non-AGA+ and AGA+ NSCLC
- Deeper, Broader, or Smarter? The Race for the Best Minimal Residual Disease Assay Remains Wide Open
- Cytisine for Smoking Cessation in Lung Cancer Screening Participants: Promise, Caveats, and a Path Forward
- Tarlatamab in Pulmonary Carcinoid: A Signal Worth Chasing, Carefully
- Smoking and Cessation Across the Continuum of Cancer Care: 20 Years of Progress Toward Cessation as Standard Cancer Treatment
- Ending Tobacco Use Without Redistributing Tobacco Harm
- Clinical Responses to Tarlatamab Among Patients With Pulmonary Carcinoid
- Cytisine for Smoking Cessation Within a Lung Cancer Screening Program: Results From the Italian RISP Trial